HEREGULIN ACTIVATION OF SCHWANN CELLS
HEREGULIN ACTIVATION OF SCHWANN CELLS
批准号:
6763130
负责人:
David J. Carey
金额:
$23.33万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2000
资助国家:
美国
项目状态:
已结题
起止时间:
2000-07-06 至 2006-06-30
关键词:
Schwann cellsbiological signal transductioncarbohydrate biosynthesiscell differentiationcell growth regulationcell proliferationcomplementary DNAenzyme activitygene deletion mutationheparan sulfateheregulinmitogen activated protein kinaseneuronsnewborn animalsphosphorylationpolymerase chain reactionprotein bindingprotein degradationprotein isoformsprotein structure functionproteoglycanreceptor bindingsite directed mutagenesisspinal gangliontissue /cell culture
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION(Verbatim from Applicant's Abstract): The long-range goal of this
project is to elucidate the molecular mechanisms that control Schwann cell
differentiation. The aim of the current application is to investigate the
mechanisms by which heregulin growth factors activate signaling receptors on
Schwann cells. Heregulins are key regulators of Schwann cell proliferation,
differentiation, and survival. Nerve cells are a major source of heregulins in
peripheral nerves, and heregulins associated with axonal membranes have been
shown to promote Schwann cell proliferation and survival. At least 12 heregulin
isoforms are known to be produced by alternative splicing. These isoforms
exhibit considerable structural variability. Heregulins activate intracellular
signaling pathways in Schwann cells by binding to the transmembrane receptor
kinases erbB2 and erbB3. Receptor binding is mediated by a conserved domain of
approximately 50 amino acids that is present in all heregulins. The proposed
experiments will examine the hypothesis that structural differences among
heregulin isoforrns alter their ability to interact with target cells, such as
Schwann cells. This results, in part, from differences in membrane association
and interaction of certain heregulin isoforms with cell surface heparan sulfate
molecules. The specific aims address the following questions related to
heregulin function and Schwann cells. What are the effects of differences in
heregulin structure on receptor binding, internalization and activation of
Schwann cells? How does interaction with heparan sulfate proteoglycans affect
the activity of heregulins? These studies will be carried out with rat Schwann
cells grown in tissue culture and recombinant heregulins. Mutagenesis of
heregulin isoforms will be used to identify particular structural domains that
produce functional differences. The information derived from these studies will
facilitate the understanding and treatment of human diseases of the peripheral
nervous system and regeneration
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
Geisinger eGenonic Medicine (GeM) Program
-
批准号:8193653
-
项目类别:
-
资助金额:$84.18万
-
财政年份:2011
-
负责人:David J. Carey
-
依托单位:
Geisinger eGenonic Medicine (GeM) Program
-
批准号:8509382
-
项目类别:
-
资助金额:$35.48万
-
财政年份:2011
-
负责人:David J. Carey
-
依托单位:
Geisinger eGenonic Medicine (GeM) Program
-
批准号:8725716
-
项目类别:
-
资助金额:$100.92万
-
财政年份:2011
-
负责人:David J. Carey
-
依托单位:
Geisinger eGenonic Medicine (GeM) Program
-
批准号:8517172
-
项目类别:
-
资助金额:$106.38万
-
财政年份:2011
-
负责人:David J. Carey
-
依托单位:
Geisinger eGenonic Medicine (GeM) Program
-
批准号:8720225
-
项目类别:
-
资助金额:$15.28万
-
财政年份:2011
-
负责人:David J. Carey
-
依托单位:
Geisinger eGenonic Medicine (GeM) Program
-
批准号:8319355
-
项目类别:
-
资助金额:$78.78万
-
财政年份:2011
-
负责人:David J. Carey
-
依托单位:
Geisinger eGenonic Medicine (GeM) Program
-
批准号:8518008
-
项目类别:
-
资助金额:$11.97万
-
财政年份:2011
-
负责人:David J. Carey
-
依托单位:
HEREGULIN ACTIVATION OF SCHWANN CELLS
-
批准号:6394430
-
项目类别:
-
资助金额:$23.33万
-
财政年份:2000
-
负责人:David J. Carey
-
依托单位:
HEREGULIN ACTIVATION OF SCHWANN CELLS
-
批准号:6606239
-
项目类别:
-
资助金额:$23.33万
-
财政年份:2000
-
负责人:David J. Carey
-
依托单位:
HEREGULIN ACTIVATION OF SCHWANN CELLS
-
批准号:6540416
-
项目类别:
-
资助金额:$23.33万
-
财政年份:2000
-
负责人:David J. Carey
-
依托单位:
HEREGULIN ACTIVATION OF SCHWANN CELLS
-
批准号:6321887
-
项目类别:
-
资助金额:$23.33万
-
财政年份:2000
-
负责人:David J. Carey
-
依托单位:
SCHWANN CELL GROWTH FACTOR SIGNALING
-
批准号:6187177
-
项目类别:
-
资助金额:$3.37万
-
财政年份:1999
-
负责人:David J. Carey
-
依托单位:
SCHWANN CELL GROWTH FACTOR SIGNALING
-
批准号:2842879
-
项目类别:
-
资助金额:$20.3万
-
财政年份:1999
-
负责人:David J. Carey
-
依托单位:
SCHWANN CELL GROWTH FACTOR SIGNALING
-
批准号:6330552
-
项目类别:
-
资助金额:$16.85万
-
财政年份:1999
-
负责人:David J. Carey
-
依托单位:
SCHWANN CELL GROWTH FACTOR SIGNALING
-
批准号:6539991
-
项目类别:
-
资助金额:$20.18万
-
财政年份:1999
-
负责人:David J. Carey
-
依托单位:
SCHWANN CELL GROWTH FACTOR SIGNALING
-
批准号:6393951
-
项目类别:
-
资助金额:$19.78万
-
财政年份:1999
-
负责人:David J. Carey
-
依托单位:
VASCULAR SMOOTH MUSCLE MEMBRANE PROTEOGLYCANS
-
批准号:2224809
-
项目类别:
-
资助金额:$18.84万
-
财政年份:1993
-
负责人:David J. Carey
-
依托单位:
VASCULAR SMOOTH MUSCLE MEMBRANE PROTEOGLYCANS
-
批准号:3367884
-
项目类别:
-
资助金额:$19.98万
-
财政年份:1993
-
负责人:David J. Carey
-
依托单位:
VASCULAR SMOOTH MUSCLE MEMBRANE PROTEOGLYCANS
-
批准号:2224808
-
项目类别:
-
资助金额:$19.01万
-
财政年份:1993
-
负责人:David J. Carey
-
依托单位:
SKELETAL MUSCLE HYDROPHOBIC PROTEOGLYCANS
-
批准号:2291581
-
项目类别:
-
资助金额:$2.25万
-
财政年份:1992
-
负责人:David J. Carey
-
依托单位:
海外基金